Lazard Asset Management’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-59,432
Closed -$14.6M 2624
2022
Q3
$14.6M Buy
59,432
+2,713
+5% +$733K 0.02% 492
2022
Q2
$14M Buy
56,719
+19,601
+53% +$5.29M 0.02% 521
2022
Q1
$12.3M Buy
37,118
+8,901
+32% +$2.74M 0.01% 568
2021
Q4
$10.1M Buy
28,217
+14,555
+107% +$4.92M 0.01% 625
2021
Q3
$4.45M Sell
13,662
-565
-4% -$191K 0.01% 778
2021
Q2
$4.44M Buy
14,227
+13,971
+5,457% +$4.29M 0.01% 739
2021
Q1
$81K Buy
256
+12
+5% +$3.84K ﹤0.01% 1256
2020
Q4
$79K Buy
+244
New +$67.5K ﹤0.01% 1239
2020
Q3
Sell
-539
Closed -$130K 1781
2020
Q2
$130K Sell
539
-410
-43% -$82.3K ﹤0.01% 969
2020
Q1
$137K Buy
949
+419
+79% +$69.6K ﹤0.01% 954
2019
Q4
$90K Buy
530
+399
+305% +$74K ﹤0.01% 974
2019
Q3
$23K Buy
+131
New +$28.3K ﹤0.01% 1058
2019
Q2
Sell
-2,326
Closed -$664K 1269
2019
Q1
$664K Buy
+2,326
New +$773K ﹤0.01% 887
2016
Q1
Sell
-1,120
Closed -$101K 1127
2015
Q4
$101K Buy
1,120
+120
+12% +$10.2K ﹤0.01% 891
2015
Q3
$92K Sell
1,000
-600
-38% -$52.9K ﹤0.01% 869
2015
Q2
$105K Buy
+1,600
New +$106K ﹤0.01% 909

Other funds holding ABMD

Lazard Asset Management's ABMD Position: Q4 2022 in Review

Lazard Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 59,432 shares — an estimated $14.6M sold.

Lazard Asset Management first reported a position in ABMD in Q2 2015 and held it in 16 quarters. The position peaked at $14.6M in Q3 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Lazard Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Lazard Asset Management sold 59,432 Abiomed Inc shares in Q4 2022, an estimated $14.6M.
  • Lazard Asset Management first reported a position in Abiomed Inc in Q2 2015 and held it in 16 quarters.
  • Lazard Asset Management's Abiomed Inc position peaked at $14.6M in Q3 2022.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Lazard Asset Management's 13F filing for Q4 2022, filed 15 Feb 2023.